Pfizer Storing Up $330M To Settle Menopause Drug Suits

Law360, New York (June 19, 2012, 7:55 PM EDT) -- Pfizer Inc. has set aside $330 million to settle multidistrict litigation and other remaining claims over injuries allegedly caused by hormone replacement therapies such as Prempro, a sum that would bring the drugmaker's total litigation losses to $1.2 billion, according to a regulatory filing last month.

About 40 percent of the 10,000 suits filed to date over the drugs are still pending in U.S. federal and state courts and in Canada, Pfizer said in a May 10 filing with the U.S. Securities and Exchange Commission. The...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In Re: Prempro Products et al


Case Number

4:03-cv-01507

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Billy Roy Wilson

Date Filed

March 7, 2003

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.